Literature DB >> 6122791

Salicylazobenzoic acid in ulcerative colitis.

A Bartalsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6122791     DOI： 10.1016/s0140-6736(82)91956-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Eudragit S-100 entrapped chitosan microspheres of valdecoxib for colon cancer.

Authors:  Naveen K Thakral; Alok R Ray; Dipak K Majumdar
Journal:  J Mater Sci Mater Med       Date:  2010-06-10       Impact factor: 3.896

Review 2.  Prostaglandins and other mediators in food intolerance.

Authors:  M H Lessof; J B Anderson
Journal:  Clin Rev Allergy       Date:  1984-02

3.  Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting.

Authors:  Amol Paharia; Awesh K Yadav; Gopal Rai; Sunil K Jain; Shyam S Pancholi; Govind P Agrawal
Journal:  AAPS PharmSciTech       Date:  2007-02-16       Impact factor: 3.246

Review 4.  Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

5.  Superoxide inhibition following different stimuli of respiratory burst and metabolism of aminosalicylates in neutrophils.

Authors:  H Allgayer; S Rang; U Klotz; P Böhne; J Retey; W Kruis; R Gugler
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

6.  Olsalazine versus placebo in the treatment of mild to moderate ulcerative colitis: a randomised double blind trial.

Authors:  G E Feurle; D Theuer; S Velasco; B A Barry; D Wördehoff; A Sommer; G Jantschek; W Kruis
Journal:  Gut       Date:  1989-10       Impact factor: 23.059
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.